-
Product Insights
New![]()
Tidal Flat Photovoltaic Project
Tidal Flat Photovoltaic Project is a solar PV project located in Zhejiang, China. The project is at the permitting stage. Empower your strategies with our Tidal Flat Photovoltaic Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
New![]()
Tidal Flat Solar PV Park
Tidal Flat Solar PV Park is a solar PV project located in Zhejiang, China. The project is owned and developed by Sinohydro Corp Ltd. The project is currently partially active. Empower your strategies with our Tidal Flat Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
New![]()
Zhejiang Solar Tidal Solar PV Park
Zhejiang Solar Tidal Solar PV Park is a solar PV project located in Zhejiang, China. The project came online in 2022. Empower your strategies with our Zhejiang Solar Tidal Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Solid Tumor Drug Details: TIDAL-01 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Metastatic Uveal Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Metastatic Uveal Melanoma Drug Details: TIDAL-01 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Metastatic Colorectal Cancer Drug Details: TIDAL-01 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Non-Small Cell Lung Cancer Drug Details: TIDAL-01 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Triple-Negative Breast Cancer (TNBC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Triple-Negative Breast Cancer (TNBC) Drug Details: TIDAL-01 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Head And Neck Squamous Cell Carcinoma (HNSC)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Head And Neck Squamous Cell Carcinoma (HNSC) Drug Details: TIDAL-01 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Head And Neck Cancer Squamous Cell Carcinoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details: TIDAL-01 is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TIDAL-01 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TIDAL-01 in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer) Drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Donepezil SR in Dementia Associated With Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Donepezil SR in Dementia Associated With Alzheimer's Disease Drug Details: Donepezil (GB-5001) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Hydrovax-YFV in Yellow Fever
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Hydrovax-YFV in Yellow FeverDrug Details:Hydrovax-YFV is under development for the prevention of yellow fever. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CDR-132L in Congestive Heart Failure (Heart Failure)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CDR-132L in Congestive Heart Failure (Heart Failure) Drug Details:CDR-132L is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AC-0176 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AC-0176 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:ACÂ-0176 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Tiratricol in Allan-Herndon-Dudley Syndrome (Monocarboxylate Transporter-8 Deficiency)Drug Details:Tiratricol is under development for the treatment of monocarboxylate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ZED-1227 in Non Alcoholic Fatty Liver Disease (NAFLD)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ZED-1227 in Non Alcoholic Fatty Liver Disease (NAFLD) Drug Details: ZED-1227 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BIIB-080 in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BIIB-080 in Alzheimer's Disease Drug Details: BIIB-080 is under development for the treatment of Alzheimer's...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – FPI-2059 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. FPI-2059 in Metastatic Colorectal Cancer Drug Details: IPN-01087 is under development for recurrent head and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.